Cancer is a severe disease causing millions of death worldwide every year. Cancer starts from a single cell and genetically transforms a normal cell in to tumour cell and is gradually spread to other cells. With the dramatic increase in the number of people affected by cancer, many pharmaceutical players started to invest on monoclonal antibodies. While the drugs are used for the treatment of cancer, drugs like chemotherapy agents have adverse side effects as they affect the normal cells as well along with cancerous cells. This promoted the increased usage of Monoclonal Antibodies for the treatment of cancer.
Recent years have seen the emergence of monoclonal antibodies owing to its potentiality to offer less toxic and highly efficient alternatives to the patients. The antibodies have the ability to treat many diseases related to autoimmune, inflammatory and especially cancer. The antibodies comprises of identical cells which are clones of a single parent cells and directed towards specific targets cells. Thus monoclonal antibodies due to its specificity to target only cancer cell leaving behind the healthy one, can be a more efficient way of treating cancer than chemotherapies or drugs.
The drastic increase in the people affected by cancer prompted many pharmaceutical firms to invest in monoclonal antibodies. Rise in investment in R&D of genomic studies, monoclonal antibodies ability to target only specific cells, technological innovations in target gene selection and genetic sequencing, having no side effects compared to its counter parts are the primary drivers for the market. With the increased occurrence of cancer, the market is expected to grow significantly in the next 5 years having a presence of highly strong products in the pipeline. There are also few restraints for its market entry like stringent guidelines, high cost, long durations required for R&D, clinical trials.
The Cancer Monoclonal Antibodies Market is segmented as following: Based on Application: Liver Breast Brain Blood Hodgkins and Non-Hodgkins lymphoma Colorectal Leukaemia Others Based on Type: Murine Antibodies Chimeric and Humanised Antibodies Fully Humanized Antibodies Based on Conjugate Cancer Therapies: Immunoliposome Radioimmunotherapy ADEPT Immunocytokines Others
The major companies operating in the North America Cancer Monoclonal Antibodies Market are Amgen, Bristol Myers Squibb, Roche, Immunogen, Novartis, Genmab, glaxosmithkline, Seattle Genetics, Eli Lilly, and Spectrum Pharmaceuticals.
The Cancer Monoclonal Antibodies Market study offers the following deliverables: North America, regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics Study of the effect of exogenous and endogenous factors that affect the North America market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis Study the micro environment factors that determine the overall profitability of an Industry, using Porters five forces analysis for analysing the level of competition and business strategy development A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
Checkout other related studies in the Pharmaceuticals Segment:
About Us: Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, we cater to the needs of both individual and corporate clients. Our analyst team comprises expert professionals in market research, who with their collective knowledge and skillset dedicatedly serve clients from various industries and regions.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
